Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:41 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Evaluation of the Efficacy and Safety of Treatments for Patients Hospitalized for COVID-19 Infection Without Signs of Acute Respiratory Failure, in Tunisia
NCT04528927 · Abderrahmane Mami Hospital · PHASE3 · withdrawn · last registry update 2020-08-27 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “\- Interest in the use of HCQ is controversial.” | – | Registry record, Abderrahmane Mami Hospital |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against TLR7 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2021-08-20Results posted on the registry: Baylor Research Institute, Hydroxychloroquine (NCT04333225)
- 2021-08-13Results posted on the registry: M.D. Anderson Cancer Center, gp100 + R848 gel (NCT00960752)
- 2021-08-12Also stopped (terminated): Centre Chirurgical Marie Lannelongue, Dexamethasone and Hydroxychloroquine + Hydroxychloroquine (NCT04347980)
- 2021-08-09Also stopped (withdrawn): Gangnam Severance Hospital, Hydroxychloroquine as post exposure prophylaxis (NCT04330144)
- 2021-07-29Phase 3 first posted: Health Institutes of Turkey, Hydroxychloroquine + Favipiravir (NCT04981379)
- 2021-07-27Also stopped (terminated): Jawaharlal Institute of Postgraduate Medical Education & Research, Methotrexate + Leflunomide (NCT02930343)
- 2021-07-16Phase 3 first posted: Coordinación de Investigación en Salud, Mexico, Hydroxychloroquine with Azithromycin (NCT04964583)
- 2021-06-30Results posted on the registry: University of Minnesota, Hydroxychloroquine (NCT04328467)
- 2021-06-29Also stopped (terminated): Chronic Obstructive Pulmonary Disease Trial Network, Denmark, Azithromycin + Hydroxychloroquine (NCT04322396)
- 2021-06-28Results posted on the registry: Chronic Obstructive Pulmonary Disease Trial Network, Denmark, Azithromycin + Hydroxychloroquine (NCT04322396)
- 2021-06-10Results posted on the registry: Jawaharlal Institute of Postgraduate Medical Education & Research, Methotrexate + Leflunomide (NCT02930343)
- 2021-05-26Also stopped (terminated): University of Southern California, Baricitinib + Hydroxychloroquine (NCT04373044)
- 2021-05-20Results posted on the registry: Biocon Limited, Itolizumab IV infusion + Best supportive care (BSC) (NCT04475588)
- 2021-05-17Also stopped (terminated): Duke University, Hydroxychloroquine + Azithromycin (NCT04335552)
- 2021-05-13Results posted on the registry: University of Minnesota, Hydroxychloroquine (NCT04308668)
- 2021-05-12Results posted on the registry: Duke University, Hydroxychloroquine + Azithromycin (NCT04335552)
- 2021-05-10Results posted on the registry: Hackensack Meridian Health, Hydroxychloroquine Sulfate (HCQ) (NCT04345653)
- 2021-05-05Also stopped (withdrawn): Universidad Nacional de Colombia, Hydroxychloroquine + Placebo oral tablet (NCT04346329)
- 2021-05-04Results posted on the registry: Hospital for Special Surgery, New York, Hydroxychloroquine (NCT01784523)
- 2021-05-03Also stopped (terminated): University Hospital Tuebingen, Hydroxychloroquine Sulfate + Placebo (NCT04342221)
- 2021-04-29Also stopped (terminated): Megan Landes, Hydroxychloroquine + Placebo oral tablet (NCT04374942)
- 2021-04-27Also stopped (withdrawn): Fondation Hôpital Saint-Joseph, Azithromycin + Hydroxychloroquine (NCT04365582)
- 2021-04-26Phase 3 first posted: Post Graduate Institute of Medical Education and Research, Chandigarh, Hydroxychloroquine (HCQ) (NCT04858633)
- 2021-04-22Phase 3 first posted: Ain Shams University, Remdesivir + Standard of care_1 (NCT04853901)
- 2021-04-21Results posted on the registry: Gilead Sciences, Vesatolimod + Placebo (NCT03060447)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision